• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Organon and CAF, Development Bank of Latin America Team Up to Improve Financing in Women’s Health


The collaboration will use results-based financing to achieve its goals.

Organon and CAF, Development Bank of Latin America, announced that they are collaborating to increase sustainable financing in women’s health. The two organizations will design and implement sustainable programs for women in Latin America and the Caribbean. These programs will improve equity, health, and autonomy for the women involved.

In a press release, the two organizations announced that they had signed a memorandum of understanding with the United Nations Sustainable Development Goals.

These programs will aim to provide sustainable financing to women in the targeted areas.

“At Organon, we believe that results-based financing can drive collective action to progressing women’s health goals,” Kevin Ali, Organon CEO, said in the press release. “We are proud of our first-of-its-kind collaboration with CAF, built specifically to positively affect the health of women–and ultimately a country’s economy and development.”

Pharm Exec catches up with Kevin Ali to find out how Organon, the Merck spinoff he formed, has fared in delivering on its mission of creating a global leader and difference-maker in women’s health.

Organon describes itself as a global healthcare company focused on improving women’s health.

“This agreement with Organon will help us to join forces in order to break with the structural barriers that keep limiting the access of women to health, financial and non-financial services,” Sergio Diaz-Granados, Executive President of CAF said in the press release.

Related Videos
Related Content